Arun Upadhyay - 02 Jan 2025 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Chief Scientific Officer, Head of Research, Development and Medical
Signature
/s/ Arun Upadhyay by Shankar Musunuri, his attorney-in-fact
Issuer symbol
OCGN
Transactions as of
02 Jan 2025
Net transactions value
-$37,241
Form type
4
Filing time
06 Jan 2025, 17:02:25 UTC
Previous filing
26 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCGN Common Stock Tax liability $37,241 -41,633 -12% $0.8945 306,197 03 Jan 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Award $0 +730,994 $0.000000 730,994 02 Jan 2025 Common Stock 730,994 $0.9000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests annually in equal installments over three years commencing on January 2, 2026, subject to continued service with the Issuer on the applicable vesting dates.

Remarks:

Chief Scientific Officer, Head of Research, Development and Medical